Literature DB >> 25279163

Association between LGALS2 3279C>T and coronary artery disease: A case-control study and a meta-analysis.

Jiangfang Lian1, Peiliang Fang2, Dongjun Dai3, Yanna Ba2, Xi Yang1, Xiaoyan Huang1, Junxin Li2, Xiaoliang Chen2, Jian Guo2, Feng Guan3, Ping Peng2, Ruochi Zhao3, Shangshi Zhang3, Fang Gao3, Linlin Tang3, Cheng Zhang3, Huihui Ji3, Qingxiao Hong3, Huadan Ye3, Limin Xu3, Qilong Zhong3, Panpan Liu3, Jianqing Zhou1, Shiwei Duan3.   

Abstract

Coronary artery disease (CAD) has become the main cause of mortality worldwide. Lectin galactoside-binding soluble-2 (LGALS2) is involved in the cytokine lymphotoxin-α (LTA) cascade that may influence the progress of CAD. The aim of the present study was to assess the association between the LGALS2 3279C>T (rs7291467) polymorphism and CAD. A total of 562 cases and 572 controls were recruited to examine the association. A systematic meta-analysis was performed to evaluate the contribution of LGALS2 3279C>T polymorphism to the risk of CAD among 12,093 cases and 11,020 controls. There was no significant association found in the present case-control study. However, the meta-analysis showed that LGALS2 3279C>T played a protective role in CAD [P=0.008, odds ratio (OR), 0.90; 95% confidence interval (95% CI), 0.82-0.97] and particularly in the Asian population (P=0.006; OR, 0.82; 95% CI, 0.71-0.94). The present case-control study did not find a significant association between LGALS2 3279C>T and CAD in the Eastern Han Chinese population. However, the meta-analysis indicated that LGALS2 3279C>T played a protective role in CAD, suggesting an ethnic difference in the association of the locus with CAD.

Entities:  

Keywords:  coronary artery disease; lectin galactoside-binding soluble-2 3279C>T; meta-analysis; polymorphism; rs7291467

Year:  2014        PMID: 25279163      PMCID: PMC4179692          DOI: 10.3892/br.2014.325

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  40 in total

Review 1.  Problems of reporting genetic associations with complex outcomes.

Authors:  Helen M Colhoun; Paul M McKeigue; George Davey Smith
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

2.  ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia.

Authors:  Simon-Pierre Guay; Diane Brisson; Johannie Munger; Benoit Lamarche; Daniel Gaudet; Luigi Bouchard
Journal:  Epigenetics       Date:  2012-05-01       Impact factor: 4.528

3.  LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians.

Authors:  Massimo Mangino; Peter Braund; Ravi Singh; Rick Steeds; John R Thompson; Kevin Channer; Nilesh J Samani
Journal:  Atherosclerosis       Date:  2006-11-13       Impact factor: 5.162

4.  Lymphotoxin-alpha and galectin-2 SNPs are not associated with myocardial infarction in two different German populations.

Authors:  Kamil Sedlacek; Katharina Neureuther; Jakob C Mueller; Klaus Stark; Marcus Fischer; Andrea Baessler; Wibke Reinhard; Ulrich Broeckel; Wolfgang Lieb; Jeanette Erdmann; Heribert Schunkert; Günter Riegger; Thomas Illig; Thomas Meitinger; Christian Hengstenberg
Journal:  J Mol Med (Berl)       Date:  2007-05-12       Impact factor: 4.599

5.  Lack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populations.

Authors:  A Kimura; M Takahashi; B Y Choi; S W Bae; S Hohta; T Sasaoka; K-i Nakahara; K Chida; M Sawabe; M Yasunami; T Naruse; T Izumi; J-E Park
Journal:  Tissue Antigens       Date:  2007-03

6.  Genetic susceptibility to death from coronary heart disease in a study of twins.

Authors:  M E Marenberg; N Risch; L F Berkman; B Floderus; U de Faire
Journal:  N Engl J Med       Date:  1994-04-14       Impact factor: 91.245

7.  Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans.

Authors:  Werner Koch; Petra Hoppmann; Elena Michou; Vanessa Jung; Arne Pfeufer; Jakob C Mueller; Christian Gieger; H-Erich Wichmann; Thomas Meitinger; Albert Schömig; Adnan Kastrati
Journal:  Hum Mol Genet       Date:  2007-05-21       Impact factor: 6.150

8.  Coronary artery disease in the developing world.

Authors:  Karen Okrainec; Devi K Banerjee; Mark J Eisenberg
Journal:  Am Heart J       Date:  2004-07       Impact factor: 4.749

9.  Lack of association between lymphotoxin-alpha, galectin-2 polymorphisms and coronary artery disease: a meta-analysis.

Authors:  Wenlong Li; Jing Xu; Xiaojian Wang; Jingzhou Chen; Channa Zhang; Kai Sun; Rutai Hui
Journal:  Atherosclerosis       Date:  2009-08-14       Impact factor: 5.162

10.  Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females.

Authors:  Danjie Jiang; Dawei Zheng; Lingyan Wang; Yi Huang; Haibo Liu; Leiting Xu; Qi Liao; Panpan Liu; Xinbao Shi; Zhaoyang Wang; Lebo Sun; Qingyun Zhou; Ni Li; Limin Xu; Yanping Le; Meng Ye; Guofeng Shao; Shiwei Duan
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more
  3 in total

1.  PPARG, AGTR1, CXCL16 and LGALS2 polymorphisms are correlated with the risk for coronary heart disease.

Authors:  Jianwei Tian; Shunying Hu; Feng Wang; Xuedong Yang; Yuqian Li; Congchun Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Molecular genetics of coronary artery disease.

Authors:  Kouichi Ozaki; Toshihiro Tanaka
Journal:  J Hum Genet       Date:  2015-07-02       Impact factor: 3.172

3.  Long-term outdoor air pollution and DNA methylation in circulating monocytes: results from the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Gloria C Chi; Yongmei Liu; James W MacDonald; R Graham Barr; Kathleen M Donohue; Mark D Hensley; Lifang Hou; Charles E McCall; Lindsay M Reynolds; David S Siscovick; Joel D Kaufman
Journal:  Environ Health       Date:  2016-12-01       Impact factor: 5.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.